title: FOLFIRINOX in locally advanced pancreas adenocarcinoma: back to the future?
authors.affiliation: Section of Gastrointestinal Oncology, Division of Medical Oncology, Department of Medicine, The Ohio State University/Arthur James Cancer Hospital and Richard Solove Research Institute, Columbus, Ohio 43210, USA. Tanios.Bekaii-Saab@osumc.rdu
authors.forename: Tanios
authors.initials: T
authors.lastname: Bekaii-Saab
authors.forename: Richard M
authors.initials: RM
authors.lastname: Goldberg
mesh_terms: D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage*; D006801:Humans; D000077146:Irinotecan; D002955:Leucovorin / Q000008:administration & dosage*; D008297:Male; D009944:Organoplatinum Compounds / Q000008:administration & dosage*; D000077150:Oxaliplatin; D010190:Pancreatic Neoplasms / Q000188:drug therapy*
chemical_list: D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D000077146:Irinotecan; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin